Isomorphic Labs
![]() | The topic of this article may not meet Wikipedia's general notability guideline. (January 2022) |
Isomorphic Labs is a subsidiary of Alphabet Inc. created in November 2021. Its CEO is Demis Hassabis, who also leads Alphabet subsidiary DeepMind. The company aims to use artificial intelligence for drug discovery.[1][2][3]
References[]
- ^ Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Archived from the original on November 5, 2021. Retrieved November 9, 2021.
- ^ Crist, Ry (November 4, 2021). "Alphabet launches Isomorphic Labs, an AI-driven drug discovery startup". CNET.
- ^ Coldeway, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery". TechCrunch.
External links[]
Categories:
- Google stubs
- Alphabet Inc.
- Biotechnology companies
- Drug discovery
- Artificial intelligence